|
|
40
|
|
|
1611N
|
|
|
DOCETAXEL 20MG INJ (DIL/AHI)
|
|
|
DOCETAXEL
|
|
|
DOCETAXEL
|
|
|
20MG VIAL
|
|
|
C
|
|
|
36.02
|
|
|
36.02
|
|
|
20MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
DIL
|
|
|
FRESENIUS KABI
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|